Diagnostic Value of Serum Ficolin-3 and Gal-3 in Sepsis Complicated with Acute Kidney Injury
Hang Yi,Ruiping Ye,Jinfeng Wang,Lin Gao,Weiwei Zhang,Chao Liu
DOI: https://doi.org/10.2147/ijgm.s478736
IF: 2.145
2024-11-20
International Journal of General Medicine
Abstract:Hang Yi, 1 Ruiping Ye, 2 Jinfeng Wang, 3 Lin Gao, 4 Weiwei Zhang, 4 Chao Liu 4 1 Department of Intensive Care Medicine, Qianjiang Central Hospital, Qianjiang City, Hubei Province, 433100, People's Republic of China; 2 Department of Intensive Care Medicine, The First People's Hospital of Dingnan County, Ganzhou City, Jiangxi Province, 341900, People's Republic of China; 3 Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou City, Jiangxi Province, 341000, People's Republic of China; 4 Department of Intensive Care Medicine, Ganzhou People's Hospital, Ganzhou City, Jiangxi Province, 341000, People's Republic of China Correspondence: Chao Liu, Department of Intensive Care Medicine, Ganzhou People's Hospital, No. 16, Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, People's Republic of China, Email Objective: To investigate the diagnostic value of serum fibrinogen domain-containing lectin-3 (Ficolin-3) and galectin-3 (Gal-3) in sepsis-associated acute kidney injury (SA-AKI). Methods: This study retrospectively analyzed 126 SA-AKI patients with SA-AKI and 103 septic patients without AKI as controls. Based on the severity of renal injury, the SA-AKI patients were divided into three groups: mild (41 cases), moderate (53 cases), and severe (32 cases). Serum levels of Ficolin-3 and Gal-3 were measured using ELISA, and their correlation was determined through Pearson analysis. Multivariate logistic regression was used to identify factors associated with the occurrence of SA-AKI. Results: The serum creatinine (SCr), blood urea nitrogen (BUN), as well as the expression levels of serum Ficolin-3 and Gal-3 in the SA-AKI group were higher than those in the non SA-AKI group (P< 0.05). The expression levels of Ficolin-3 and Gal-3 in the serum of the SA-AKI group were also higher than those of the non SA-AKI group (P< 0.05). The expression levels of Ficolin-3 and Gal-3 in serum gradually increased with the severity of renal injury in SA-AKI patients (P< 0.05). The expression levels of Ficolin-3 and Gal-3 in serum were greatly positively correlated (P< 0.001). Elevated levels of BUN, Ficolin-3, and Gal-3 were risk factors affecting the occurrence of SA-AKI (P< 0.05). The area under the curve (AUC) of serum Ficolin-3 and Gal-3 for individual diagnosis of SA-AKI was 0.877 and 0.867, respectively, the AUC of their combined diagnosis was 0.953, and the diagnostic sensitivity was higher than that of their individual diagnosis (P< 0.001). Conclusion: The expression levels of serum Ficolin-3 and Gal-3 are closely related to associated with the onset and progression of SA-AKI and hold diagnostic value for its detection. Furthermore, the combined use of both markers provides a more accurate diagnosis than either marker alone. Keywords: Sepsis complicated with acute kidney injury, Fibrinogen domain-containing lectin-3, Galectin-3 Sepsis is a condition triggered by the body's dysregulated response to infection, resulting in organ dysfunction. In sepsis, increased vascular permeability and altered local blood flow distribution can raise the risk of mortality. 1 Acute kidney injury (AKI) is a frequent and complex complication of sepsis. Factors such as infections, urethral obstruction, and certain medications associated with sepsis can contribute to its development. Patients with AKI often exhibit symptoms like reduced or absent urine output, nausea, and generalized edema. Statistics indicate that 50% to 70% of sepsis patients develop sepsis-associated acute kidney injury (SA-AKI), a syndrome marked by impaired renal function. This disease progresses rapidly and can become severe, potentially leading to multi-organ failure and posing a serious threat to the patient's life, health, and safety. 2,3 Therefore, finding specific biomarkers that can assist in the clinical diagnosis of SA-AKI is of great importance. Fibrinogen domain-containing lectin 3 (Ficolin-3) is one of the important members of the fibrinogen family as well as an important initiator of the complement lectin pathway. 4 Research indicates that Ficolin-3 plays a role in inflammation and immune responses by activating specific signaling pathways, thereby exerting pro-inflammatory effects and contributing to the onset and progression of inflammatory diseases. 5,6 Galectin-3 (Gal-3) is a member of the lectin family, abundantly present in the extracellular matrix of cardiomyocytes and fibroblasts, and involved in cell differentiation, proliferation, and intercellular communication. 7 Recently, scholars have found that Gal-3, as an immune-regulating protein, has a unique str -Abstract Truncated-
medicine, general & internal